P Diem
Overview
Explore the profile of P Diem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
516
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Hermanides J, Norgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan C, et al.
Diabet Med
. 2011 Feb;
28(10):1158-67.
PMID: 21294770
Aims: To investigate the efficacy of sensor-augmented pump therapy vs. multiple daily injection therapy in patients with suboptimally controlled Type 1 diabetes. Methods: In this investigator-initiated multi-centre trial (the Eurythmics...
3.
Egger A, Buehler T, Boesch C, Diem P, Stettler C, Christ E
Eur J Endocrinol
. 2010 Oct;
164(1):23-9.
PMID: 20930061
Objective: Patients with GH deficiency (GHD) are insulin resistant with an increase in visceral fat mass (FM). Whether this holds true when sedentary control subjects (CS) are matched for waist...
4.
Trepp R, Stettler C, Diem P, Christ E
Exp Clin Endocrinol Diabetes
. 2010 Feb;
118(9):596-601.
PMID: 20146168
Objective: Hypopituitarism with adult-onset growth hormone deficiency (GHD) is associated with increased cardiovascular morbidity and mortality due to premature and progressive atherosclerosis. An underlying cause of atherosclerosis is increased insulin...
5.
Bethel M, Deedwania P, Levitt N, Schmitz O, Huntsman-Labed A, Califf R, et al.
Diabet Med
. 2009 Dec;
26(12):1204-11.
PMID: 20002471
Aims: Non-alcoholic fatty liver disease (NAFLD) is associated with features of the metabolic syndrome (MetS) and may be an expression of the syndrome within the liver. Using screening data from...
6.
Krull I, Sahli R, Diem P, Stettler C
Diabet Med
. 2009 Nov;
26(10):1075-6.
PMID: 19900243
No abstract available.
7.
Liebl A, Hoogma R, Renard E, Geelhoed-Duijvestijn P, Klein E, Diglas J, et al.
Diabetes Obes Metab
. 2009 Sep;
11(11):1001-8.
PMID: 19740082
Aim: Continuous intraperitoneal insulin infusion (CIPII) with the DiaPort system using regular insulin was compared to continuous subcutaneous insulin infusion (CSII) using insulin Lispro, to investigate the frequency of hypoglycemia,...
8.
Scheidegger U, Fluck C, Scheidegger K, Diem P, Mullis P
Praxis (Bern 1994)
. 2009 Sep;
98(18):1001-5.
PMID: 19739046
Insulin replacement is the only effective treatment of type 1 Diabetes mellitus (T1DM). Nevertheless, many complementary treatments are in use for T1DM. In this study we assessed by questionnaire that...
9.
Spirk D, Lareida J, Scheidegger K, Diem P
Praxis (Bern 1994)
. 2009 Mar;
98(6):315-20.
PMID: 19291638
Rationale: National and international societies have published guidelines regarding glycaemic control in type-2 diabetes mellitus. Clinical studies have shown that glycaemic control of type-2 diabetes mellitus can be improved using...
10.
Jenni S, Oetliker C, Allemann S, Ith M, Tappy L, Wuerth S, et al.
Diabetologia
. 2008 May;
51(8):1457-65.
PMID: 18512043
Aims/hypothesis: We assessed systemic and local muscle fuel metabolism during aerobic exercise in patients with type 1 diabetes at euglycaemia and hyperglycaemia with identical insulin levels. Methods: This was a...